Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D00XZZ | ||||
| Former ID | DNC008440 | ||||
| Drug Name | 4-butyl-N-(pyridin-3-yl)benzamide | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [529389] | ||
| Formula | C16H18N2O | ||||
| Canonical SMILES | CCCCC1=CC=C(C=C1)C(=O)NC2=CN=CC=C2 | ||||
| InChI | 1S/C16H18N2O/c1-2-3-5-13-7-9-14(10-8-13)16(19)18-15-6-4-11-17-12-15/h4,6-12H,2-3,5H2,1H3,(H,18,19) | ||||
| InChIKey | KDHOWTVYQKITMO-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529389] | |
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
| Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
| Reactome | TRP channels | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
